CTAD Embargo Policies and FAQs

CTAD Embargo Policies and FAQs

The International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) is an annual conference organized and planned by Alzheimer’s disease clinical researchers to share scientific information with each other. The 10th annual CTAD will be held November 2-4 in Boston - USA.

Credentialed members of the media are allowed to receive a free registration to the conference. To request your free pass to CTAD 2017 please contact Benedicte CLEMENT at ctad@ant-congres.com.

  • When are abstracts available?
     
    • All embargoed abstracts will be made available on November 4th at 5pm Eastern Time at www.ctad-alzheimer.comOur embargo policies are strictly enforced. All research is embargoed until the date/time that it is shared at a CTAD presentation, symposia or poster session. After the abstract presentation, you may publish/write on the abstract content.
       
  • Can I discuss CTAD abstract content before the embargo lifts?
     
    • Presentation or discussion of embargoed content at satellite meetings or press conferences before the CTAD embargo lifts is prohibited.
       
  •  What is the photo/video policy at CTAD? 
     
    • Filming and photography of the CTAD 2017 proceedings and presentations, as well as any related visual materials, is prohibited.
       
  • Is the full registration/attendee list available?  
     
    • No, registration/attendee lists are not made public.

 

If you have questions concerning an embargo date and time OR filming and photography, please contact members of the CTAD Conference Committee

Europe: Benedicte Clement at ctad@ant-congres.com